Coston McIsaac & Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26K Hold
225
0.01% 426
2025
Q4
$28K Sell
225
-8
-3% -$1.04K 0.01% 403
2025
Q3
$34K Buy
233
+9
+4% +$1.36K 0.01% 367
2025
Q2
$35K Hold
224
0.01% 356
2025
Q1
$36K Hold
224
0.01% 327
2024
Q4
$36K Hold
224
0.01% 325
2024
Q3
$43 Hold
224
0.01% 305
2024
Q2
$38K Buy
224
+1
+0.4% +$166 0.01% 306
2024
Q1
$37K Hold
223
0.01% 318
2023
Q4
$44K Hold
223
0.02% 281
2023
Q3
$38K Hold
223
0.01% 286
2023
Q2
$38K Hold
223
0.01% 316
2023
Q1
$37K Sell
223
-30
-12% -$4.92K 0.01% 318
2022
Q4
$37 Hold
253
0.01% 318
2022
Q3
$37K Hold
253
0.02% 260
2022
Q2
$43K Buy
+253
New +$43.8K 0.03% 148

Other funds holding ZTS

Coston McIsaac & Partners's ZTS Position: Q1 2026 in Review

Coston McIsaac & Partners held its Zoetis (ZTS) position steady in Q1 2026 at 225 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #426.

Coston McIsaac & Partners first reported a position in ZTS in Q2 2022 and has held it in 16 quarters since. The position peaked at $44K in Q4 2023. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Coston McIsaac & Partners held 225 shares of Zoetis worth $26K as of Q1 2026.
  • Coston McIsaac & Partners left its Zoetis share count unchanged in Q1 2026.
  • Zoetis made up 0.01% of Coston McIsaac & Partners's portfolio in Q1 2026, its #426 holding.
  • Coston McIsaac & Partners first reported a position in Zoetis in Q2 2022 and has held it in 16 quarters since.
  • Coston McIsaac & Partners's Zoetis position peaked at $44K in Q4 2023.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.